Jacobs & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.5M | Buy |
61,621
+425
| +0.7% | +$91.4K | 1.33% | 23 |
|
|
2026
Q1 | $13.3M | Buy |
61,196
+2,594
| +4% | +$575K | 1.31% | 27 |
|
|
2025
Q4 | $13.4M | Sell |
58,602
-1,498
| -2% | -$341K | 1.26% | 22 |
|
|
2025
Q3 | $13.9M | Sell |
60,100
-1,539
| -2% | -$313K | 1.33% | 24 |
|
|
2025
Q2 | $11.4M | Buy |
61,639
+1,211
| +2% | +$225K | 1.14% | 33 |
|
|
2025
Q1 | $12.7M | Sell |
60,428
-186
| -0.3% | -$36.2K | 1.35% | 26 |
|
|
2024
Q4 | $10.8M | Sell |
60,614
-312
| -0.5% | -$57.4K | 1.1% | 37 |
|
|
2024
Q3 | $12M | Sell |
60,926
-919
| -1% | -$172K | 1.2% | 32 |
|
|
2024
Q2 | $10.6M | Buy |
61,845
+649
| +1% | +$108K | 1.11% | 35 |
|
|
2024
Q1 | $11.1M | Sell |
61,196
-1,737
| -3% | -$299K | 1.18% | 37 |
|
|
2023
Q4 | $9.75M | Sell |
62,933
-292
| -0.5% | -$42.6K | 1.11% | 38 |
|
|
2023
Q3 | $9.42M | Sell |
63,225
-963
| -2% | -$141K | 1.17% | 37 |
|
|
2023
Q2 | $8.65M | Sell |
64,188
-7,772
| -11% | -$1.14M | 1.03% | 43 |
|
|
2023
Q1 | $11.5M | Sell |
71,960
-2,417
| -3% | -$370K | 1.42% | 23 |
|
|
2022
Q4 | $12M | Buy |
74,377
+956
| +1% | +$147K | 1.56% | 21 |
|
|
2022
Q3 | $9.85M | Sell |
73,421
-880
| -1% | -$126K | 1.42% | 26 |
|
|
2022
Q2 | $11.4M | Sell |
74,301
-1,761
| -2% | -$269K | 1.52% | 23 |
|
|
2022
Q1 | $12.3M | Sell |
76,062
-1,527
| -2% | -$222K | 1.37% | 27 |
|
|
2021
Q4 | $10.5M | Buy |
77,589
+2,587
| +3% | +$306K | 1.09% | 42 |
|
|
2021
Q3 | $8.09M | Buy |
75,002
+4,513
| +6% | +$516K | 0.93% | 48 |
|
|
2021
Q2 | $7.94M | Sell |
70,489
-1,980
| -3% | -$223K | 0.92% | 48 |
|
|
2021
Q1 | $7.84M | Sell |
72,469
-560
| -0.8% | -$59.9K | 0.96% | 47 |
|
|
2020
Q4 | $7.83M | Buy |
73,029
+958
| +1% | +$92.1K | 1.02% | 42 |
|
|
2020
Q3 | $6.31M | Buy |
72,071
+7,209
| +11% | +$679K | 0.92% | 46 |
|
|
2020
Q2 | $6.37M | Buy |
64,862
+4,000
| +7% | +$352K | 1.04% | 36 |
|
|
2020
Q1 | $4.64M | Buy |
60,862
+4,020
| +7% | +$342K | 0.9% | 44 |
|
|
2019
Q4 | $5.03M | Buy |
56,842
+2,137
| +4% | +$177K | 0.76% | 56 |
|
|
2019
Q3 | $4.14M | Sell |
54,705
-2,854
| -5% | -$196K | 0.67% | 60 |
|
|
2019
Q2 | $4.18M | Sell |
57,559
-2,516
| -4% | -$198K | 0.68% | 59 |
|
|
2019
Q1 | $4.84M | Sell |
60,075
-2,622
| -4% | -$215K | 0.82% | 46 |
|
|
2018
Q4 | $5.78M | Sell |
62,697
-9,056
| -13% | -$796K | 1.14% | 38 |
|
|
2018
Q3 | $6.79M | Buy |
71,753
+2,188
| +3% | +$207K | 1.15% | 40 |
|
|
2018
Q2 | $6.45M | Sell |
69,565
-995
| -1% | -$97.2K | 1.17% | 39 |
|
|
2018
Q1 | $6.68M | Sell |
70,560
-2,225
| -3% | -$244K | 1.23% | 37 |
|
|
2017
Q4 | $7.04M | Sell |
72,785
-2,990
| -4% | -$282K | 1.27% | 36 |
|
|
2017
Q3 | $6.73M | Sell |
75,775
-1,744
| -2% | -$133K | 1.27% | 36 |
|
|
2017
Q2 | $5.62M | Sell |
77,519
-362
| -0.5% | -$24.3K | 1.11% | 41 |
|
|
2017
Q1 | $5.07M | Sell |
77,881
-542
| -0.7% | -$34.1K | 1.04% | 40 |
|
|
2016
Q4 | $4.91M | Buy |
78,423
+155
| +0.2% | +$9.46K | 1.07% | 41 |
|
|
2016
Q3 | $4.94M | Buy |
78,268
+745
| +1% | +$48.2K | 1.1% | 41 |
|
|
2016
Q2 | $4.8M | Buy |
77,523
+3,365
| +5% | +$205K | 1.13% | 39 |
|
|
2016
Q1 | $4.24M | Buy |
74,158
+1,028
| +1% | +$57.3K | 1.02% | 39 |
|
|
2015
Q4 | $4.01M | Buy |
73,130
+2,440
| +3% | +$141K | 1.04% | 39 |
|
|
2015
Q3 | $3.85M | Buy |
70,690
+1,914
| +3% | +$125K | 1.02% | 41 |
|
|
2015
Q2 | $4.62M | Sell |
68,776
-64
| -0.1% | -$4.18K | 1.16% | 34 |
|
|
2015
Q1 | $4.03M | Buy |
68,840
+12,300
| +22% | +$743K | 1.02% | 42 |
|
|
2014
Q4 | $3.7M | Buy |
56,540
+3,315
| +6% | +$209K | 0.97% | 44 |
|
|
2014
Q3 | $3.07M | Buy |
53,225
+237
| +0.4% | +$13.2K | 0.87% | 53 |
|
|
2014
Q2 | $2.29M | Sell |
52,988
-1,316
| -2% | -$69K | 0.66% | 63 |
|
|
2014
Q1 | $2.79M | Buy |
54,304
+405
| +0.8% | +$20.5K | 0.87% | 50 |
|
|
2013
Q4 | $2.85M | Sell |
53,899
-175
| -0.3% | -$8.6K | 0.91% | 49 |
|
|
2013
Q3 | $2.42M | Sell |
54,074
-1,575
| -3% | -$69.8K | 0.84% | 52 |
|
|
2013
Q2 | $2.3M | Buy |
+55,649
| New | +$2.43M | 0.83% | 48 |
|
Other funds holding ABBV
ECSS
ATO
Jacobs & Co's ABBV Position: Q2 2026 in Review
Jacobs & Co increased its AbbVie (ABBV) stake by 0.69% in Q2 2026, buying an estimated $91.4K and bringing the position to 61,621 shares worth $15.5M. The position accounts for 1.33% of the portfolio, ranked #23.
Jacobs & Co first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Jacobs & Co held 61,621 shares of AbbVie worth $15.5M as of Q2 2026.
- Jacobs & Co bought 425 AbbVie shares in Q2 2026, an estimated $91.4K.
- AbbVie made up 1.33% of Jacobs & Co's portfolio in Q2 2026, its #23 holding.
- Jacobs & Co first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Jacobs & Co's 13F filing for Q2 2026, filed 9 Jul 2026.